In addition, APOC1 is the only known endogenous cholesteryl ester transfer protein inhibitor, and this constitutive effect of APOC1 is impaired in coronary artery disease with dyslipidemia (Sacks et al., 2020). This evidence concerns the gene APOC1 and coronary artery disorder.